谢红鹰博士是贝莱德集团的总经理兼投资组合经理,也是健康科学团队的负责人。她是健康科学股票投资组合的投资经理。谢女士在该公司的服务可以追溯到2001年,包括她在2005年与贝莱德合并的State Street Research&Management(SSRM)的多年工作经验。在SSRM,她是负责管理State Street的高级副总裁兼投资经理,负责健康科学基金。在2001年加入State Street Research之前,谢女士从1999年开始担任Sanford Bernstein的制药行业研究员。从1994年到1997年,她是哥伦比亚大学的博士后研究科学家。谢女士于1988年获得北京大学化学学士学位,1993年获得加州大学洛杉矶分校生物化学博士学位,1999年获得麻省理工学院斯隆管理学院工商管理硕士学位。

 

Erin Xie, PhD, Managing Director and portfolio manager, is the head of the Health Sciences team, part of BlackRock’s Active Equity Group. She is the portfolio manager for the Health Sciences equity portfolios.

Ms. Xie’s service with the firm dates back to 2001, including her years with State Street Research & Management (SSRM), which merged with BlackRock in 2005. At SSRM, she was a Senior Vice President and portfolio manager responsible for managing the State Street Health Sciences Fund. Prior to joining State Street Research in 2001, Ms. Xie was a research associate with Sanford Bernstein covering the pharmaceutical industry from 1999. From 1994 until 1997, she was a post doctoral research scientist at Columbia University.

Ms. Xie earned a BS degree in chemistry from Beijing University in 1988, a PhD degree in Biochemistry from the University of California, Los Angeles, in 1993 and a MBA degree from the Massachusetts Institute of Technology Sloan School of Management in 1999.